The American Society of Dermatopathology

Abstract Presentations

Oral Abstract Presentations

AMA PRA Category 1 CreditsTM

These presentations will have a mix of case reports, clinical studies and basic science presentations. Resident and fellow-in-training oral abstract presenters are eligible for the ASDP Physician-in-Training Awards. Award recipients will be announced online after the annual meeting. 

Thursday, October 21

Oral Abstract Session 1 - 8:45 a.m. to 9:15 a.m. CT
Speaker   Title
     
Maryam Abdollahi, MD   Assessment of Folliculotropism in Primary Scalp Melanomas
     
Annalise K. Ajmani, BS
 
  Vaccine-associated Transient Acantholysis (VATA): A Study of Transient Acantholytic Dermatitis Following mRNA Vaccination Against COVID-19
     
Amy L. Austin, MD   Cutaneous Reactions After COVID-19 Vaccination
     
Oral Abstract Session 2 - 10:40 a.m. to 11:10 a.m. CT
Speaker   Title
     
Buket Bagci, MD   Histopathologic Features of Paraneoplastic Granuloma Annulare (PGA)
     
Sarah Benton, BA
 
  Impact of Next Generation Sequencing on Interobserver Agreement and Diagnosis of Spitzoid Neoplasms
     
Matthew Burky, DO
 
  PRAME Positivity Supports Inclusion of Lentiginous Melanoma as a Variant Pattern of Malignant Melanoma
     
Oral Abstract Session 3 - 2:00 p.m. to 3:00 p.m. CT
Speaker   Title
     
Jeffrey M. Cloutier, MD, PhD

 
  Clinical, Histopathologic, and Genomic Features of Melanocytic Tumors with Amplification of Mutant NRAS
 
     
Ashley P. Craddock, MD
 
  INI-1 Deficient Melanoma: A Potential Diagnostic Pitfall
 
     
William Damsky, MD, PhD
 
  RNA in situ Hybridization Permits Evaluation of Treatment Relevant Cytokines in Routine Skin Biopsies of Atopic Dermatitis and Psoriasis
     
Yahya Daneshbod, MD
 
  Identifying Signature Genes Helpful in Differentiation of Malignant Skin Adnexal Tumors from Primary Breast Carcinoma
     
Joshua F. Goldsmith, DO   Clonal Seborrheic Keratosis: The Risk of Recurrence and Progression to Carcinoma
     
Abhinav Grover, MBBS, MD, MS
 
  Accuracy of Deep Learning-based Artificial Intelligence in Diagnosis of Dermatopathological Lesions: A Systematic Review and Meta-analysis
 
     
Friday, October 22
Oral Abstract Session 4 - 10:00 a.m. to 10:30 a.m. CT
Speaker   Title
     
Shadi Khalil, MD, PhD   Site and Sex-associated Molecular Differences in Advanced Basal Cell Carcinomas
     
Scott C. Bresler, MD, PhD   PRAME Expression in Challenging Tumors with Melanocytic Differentiation
     
Valerie A. Larson, MD, PhD
 
  Clinical and Histopathological Spectrum of Delayed Adverse Cutaneous Reactions Following COVID-19 Vaccination
     
Oral Abstract Session 5 - 12:30 p.m. to 1:30 p.m. CT
Speaker   Title
     
Aofei Li, MD   TERT Promoter Mutation Profiles Differ in Basaloid Neoplasms
     
Johanny Lopez Dominquez   Calciphylaxis Secondary to Fibroblast Growth Factor Receptor Inhibitor
     
Timothy N. Maxwell, BS
 
  Assessment of Specificity of Dermatopathologic Immunophenotypic Criteria for IgG4-related Skin Disease
     
Elisabeth Miller, MD   Molecular Profiling of BAP-1 Inactivated Melanoma
     
Jakob M.T. Moran, MD   Novel and Rare Fusions of Potential Clinical Significance in Melanoma
     
Quoc-Bao Nguyen, MD, MBA   Trends in Medicare Reimbursement within Dermatopathology: 2011-2021
     
Saturday, October 23
Oral Abstract Session 6 - 9:00 a.m. to 9:30 a.m. CT
Speaker   Title
     
Harrison P. Nguyen, MD, MBA, MPH   Virtual Teledermatopathology Clinicopathologic Correlation Rounds for Trainee Skin Biopsies: A Quality Improvement Project
     
     
Julie D.R. Reimann, MD, PhD
 
  Toward Optimization of the Cutaneous Direct Immunofluorescence Assay: A Reassessment of Clinical and Laboratory Utilization
     
Forrest Roberson, BS   Risk Factors for Persistence of Cutaneous Squamous Cell Carcinoma Following Broad Shave Biopsy
     
Oral Abstract Session 7 - 10:30 a.m. to 11:00 a.m. CT
Speaker   Title
     
Krasimira Rozenova, MD, PhD
 
  Atypical Squamous Proliferation Diagnosed on Biopsy: Comprehensive Clinical Follow-up with Emphasis on Final Diagnosis of Squamous Cell Carcinoma
     
Hadir Shakshouk, MBBS
 
  Histopathological Features with Correlations to Systemic Manifestations of Dermatomyositis: Analysis of 42 Skin Biopsy Specimens from 22 Patients
     
Kathleen M. Sheahon, MD   The Ciliation Index is an Informative Morphologic Diagnostic Tool that Compliments Expert Review
     
Sunday, October 24
Oral Abstract Session 8 - 10:00 a.m. to 10:30 a.m. CT
Speaker   Title
     
Justin T. Snow, MD
 
  Cutaneous Metastases of Non-cutaneous Neuroendocrine Neoplasms: A Histopathologic Review of 15 Cases
     
Ourania Parra, MD
 
  Investigation of CDKN2A Copy Number Variation by FISH in FFPE Biopsies of Tumor-Stage Mycosis Fungoides
     
Marie Syku, BA
 
  Rapid and Inexpensive Detection of the Commonest CNV in Melanoma: Sensitive and Specific Quantitation of RREB1 CNV Using Droplet Digital PCR in FFPE
     
Oral Abstract Session 9 - 12:30 p.m. to 1:30 p.m. CT
Speaker   Title
     
Burak Tekin, MD   CDX2 in Dermatopathology – Case Series and Review of the Literature
     
Julie Y. Tse, MD
 
  Comprehensive Genomic Profiling Study of Lymphatic Malformations Reveals Distinct Histologic-genomic Correlations and Therapeutic Targets
     
Grace Wang, MD
 
  Interobserver Variability in Differentiated Vulvar Intraepithelial Neoplasia Between Surgical Pathology Subspecialties
     
Erik A. Williams, MD
 
  Integrated Analysis of Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry in Melanoma
     
Glenda R. Wright, MBBCh   Characterisation of CD56 Immunohistochemistry and Mast Cell Distribution in Cellular Neurothekeoma
     
Jeffrey Zhao, BA
 
  PRAME Expression Correlates with Genomic Aberration and Malignant Diagnosis of Spitzoid Melanocytic Neoplasms


Learning Objectives
Upon completion of these sessions, participants should be able to:

  • Identify various clinical and basic science topics within dermatopathology.
  • Exemplify and promote exchange of new ideas and concepts within the field of dermatopathology.
  • Describe innovative investigative studies and tools pertaining to bench and translational research.
  • Compare unique pathological perspectives and concepts as they relate to individual and groups of cases.

Poster Presentations

On-Demand Access 24/7

AMA PRA Category 1 CreditTM
 
Participants will earn 1 AMA PRA Category 1 Credit™ for each Poster Abstract Defense Session attended.
 
Basic research, practical techniques and new clinical or histopathologic entities will be presented in this traditional and popular format. Posters will be on display in two poster sessions. Residents and fellows-in-training are eligible for the ASDP Physician-in-Training Awards. Award recipients will be notified by email after the meeting.

Defense Sessions
The defense sessions will provide an opportunity for discussion between poster presenters and attendees. Presenters are asked to make every effort to attend the defense sessions.
 
     Poster Defense Session 1 (Group 1):
     Thursday, October 21
     1:00 p.m. - 2:00 p.m. Central Time

     Poster Defense Session 2 (Group 2):
     Friday, October 22
     1:30 p.m. - 2:30 p.m. Central Time

     Poster Defense Session 3 (Group 3):
     Saturday, October 23
     1:30 p.m. - 2:30 p.m. Central Time

     Poster Defense Session 4 (Group 4):
     Sunday, October 24
     1:30 p.m. - 2:30 p.m. Central Time
 
Learning Objectives
After attending the Poster Defense Sessions, participants should be able to:

  • Identify practical techniques in dermatopathology.
  • Name new clinical or histopathological entities.